Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

 SummaryNewsCalendarCompanyFinancials 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases.The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial against... 
More about the company
Latest news on CEL-SCI CORPORATION
03:16p CEL SCI : NEW STORY CEL-SCI Announces the Closing of its $5 Million Registered D..
03:04p CEL SCI : Announces the Closing of Its $5 Million Registered Direct Offering
08/24 CEL SCI CORP : Entry into a Material Definitive Agreement, Financial Statements ..
08/23 CEL SCI : Announces $5 Million Registered Direct Offering
08/11 CEL SCI : Reports Monthly Patient Enrollment in July for Its Phase 3 Head and Ne..
08/10 CEL SCI : NEW STORY CEL-SCI Corporation Reports Third Quarter Fiscal Year 2016 F..
08/10 CEL SCI : reports 3Q loss
08/10 CEL-SCI CORPORATION : Reports Third Quarter Fiscal Year 2016 Financial Results
08/09 CEL SCI : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
08/01 CEL SCI : NEW STORY CEL-SCI Reports Monthly Patient Enrollment in July for Its P..
More news
Sector news : Bio Therapeutic Drugs
09:29aDJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJPFIZER : to Acquire Key Drug -- WSJ
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Geert R. Kersten CEO, CFO, Treasurer, Director & CAO
Maximilian de Clara President & Director
Patricia B. Prichep Secretary & Senior Vice President-Operations
Eyal Talor Chief Scientific Officer
Alexander G. Esterhazy Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CEL-SCI CORPORATION75
AMGEN, INC.5.94%128 696
GILEAD SCIENCES, INC.-21.17%105 269
CELGENE CORPORATION-9.16%84 325
REGENERON PHARMACEUTIC..-25.77%42 431
VERTEX PHARMACEUTICALS..-22.84%24 057
More Results